SORT BY

FILTER BY

perks

also on other fortune lists

100 Best Companies to Work For

Courtesy of Regeneron Pharmaceuticals

75

Regeneron Pharmaceuticals

This highly productive, fast-growing biotech is led by physician-scientists (not businesspeople), and its employees are inspired by a sense of “endless possibilities.” Those vast opportunities are professional as well as scientific. The drugmaker has created a path for research associates to work their way up to the rank of scientist—rather than having to slave away for a Ph.D.—and it encourages collaboration across the company through popular “lab warmings,” firm-wide networking events where teams showcase their work.

Read Great Place to Work review here.

Looking for leads, investment insights, or competitive intelligence?

Rank last year

49

Years on list

5

HQ location

Tarrytown, N.Y.

Employees

6,500

Job openings (as of February 2019)

350

Industry

Biotechnology & Pharmaceuticals

Revenue, 2018 or most recent year ($M)

$6,711

Year founded

1988

Type of organization

Public

Number of work sites

7

Perks
offers
On-site fitness/subsidized gym
Non-discrimination policy includes sexual orientation
College tuition reimbursement
Student loan debt repayment
Diversity
% Minorities25%
% African-American/Black4%
% Asian14%
% Caucasian/White59%
% Hispanic/Latino5%
% Native American/Alaska Native-
% Native Hawaiian/Pacific Islander-
% Two or more races2%
% Unknown ethnicity16%
Paid Time Off
General PTO40
# Sick days-
Compensation
Most common job (for salaried employee)-
Avg. base pay (salaried)-
Avg. extra compensation (salaried)-
Total pay for most common job (salaried)-
Hiring/Staffing (Past 12 Months)
Full-time and part-time job growth25%
# of job applicants47,547
Avg. # of applicants per opening20
# New graduates hired234

News about Regeneron Pharmaceuticals

Why Amgen Is Lowering the Price of Cholesterol Drug Repatha By 60%

Amgen says Repatha sold $271 million in the first half of 2018, despite earlier predictions of multi-billion-dollar sales.

Read More →
The Diseases We Aren't Curing—And Why

Drug makers are flocking to certain treatment types. Why do others get left behind?

Read More →
Could a Vaccine Prevent High Cholesterol and Heart Disease?

Scientists are ready to move an experimental treatment into phase 1 trials.

Read More →
Trump's Proposed Science Cuts Could Devastate Future Generations, Pharma Expert Says

“We should only be working on two things, health and the freaking environment.”

Read More →